BD Acquires Tepha to Boost its Surgical Mesh Portfolio
Shots:
- The acquisition will utilize Tepha’s resorbable polymer technology to boost the growth of BD's surgical mesh portfolio for the repair and regeneration of soft tissues
- The acquisition also provides strategic vertical integration for BD's Phasix mesh products & includes Tepha’s GalaFLEX portfolio which is based on the novel P4HB polymer
- Additionally- an interventional segment of BD plans to extend the use of Tepha’s technology to multiple medical applications & helps the transformation of soft tissue repair and regeneration
| Ref: PR Newswire | Image: Seeking Alpha
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com